Loading…
Untreated duration predicted the severity of depression at the two-year follow-up point
No study has investigated the impact of the duration of untreated depression (DUD) on the severity of depression at the two-year follow-up point in patients with major depressive disorder (MDD) who discontinued pharmacotherapy. This study aimed to investigate this issue. This study enrolled 155 subj...
Saved in:
Published in: | PloS one 2017-09, Vol.12 (9), p.e0185119-e0185119 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c577t-b90f9b39614af0a7a48d734d1d4cade5f8cdb30fec91c00b2dbc55ae93d67af13 |
---|---|
cites | cdi_FETCH-LOGICAL-c577t-b90f9b39614af0a7a48d734d1d4cade5f8cdb30fec91c00b2dbc55ae93d67af13 |
container_end_page | e0185119 |
container_issue | 9 |
container_start_page | e0185119 |
container_title | PloS one |
container_volume | 12 |
creator | Hung, Ching-I Liu, Chia-Yih Yang, Ching-Hui |
description | No study has investigated the impact of the duration of untreated depression (DUD) on the severity of depression at the two-year follow-up point in patients with major depressive disorder (MDD) who discontinued pharmacotherapy. This study aimed to investigate this issue.
This study enrolled 155 subjects with MDD at baseline, and 101 subjects who had discontinued pharmacotherapy for 17.1 ± 5.8 months were assessed at the two-year follow-up point. DUD was defined as the interval between the onset of the index major depressive episode and the start of pharmacotherapy. The 17-item Hamilton Depression Rating Scale (HAMD) was used to evaluate depression. Multiple linear regressions were used to examine the impacts of DUD on the severity and improvement percentage (IP) of depression at follow-up.
A longer DUD was significantly associated with a greater severity and a lower IP of depression at follow-up. After controlling for confounding factors, DUD was the most significant factor predicting the severity and IP of depression at follow-up. DUD was more strongly associated with the prognosis of depression at follow-up than depression and anxiety severities at baseline.
The DUD at baseline independently predicted the severity of depression at the two-year follow-up point. Although the patients had discontinued pharmacotherapy for nearly 1.5 years, the impact of the DUD on the severity of depression persisted at follow-up. The DUD was an important index that predicted the severity of depression at the two-year follow-up point. |
doi_str_mv | 10.1371/journal.pone.0185119 |
format | article |
fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_1941324977</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_dc39061d34334aa5b41d0b1ea5817c9c</doaj_id><sourcerecordid>1942682270</sourcerecordid><originalsourceid>FETCH-LOGICAL-c577t-b90f9b39614af0a7a48d734d1d4cade5f8cdb30fec91c00b2dbc55ae93d67af13</originalsourceid><addsrcrecordid>eNptUsFq3DAQFaWlSbf9g9IaesnFW8mSLetSKKFpA4FeGnoUY2mUaPFariQn7N_Xu-uEpBSENMy89zQzPELeM7pmXLLPmzDFAfr1GAZcU9bWjKkX5JQpXpVNRfnLJ_EJeZPShtKat03zmpxUreJivk7J7-shR4SMtrBThOzDUIwRrTf7VL7FIuEdRp93RXCFxbmW0h4E-VDN96HcIcTChb4P9-U0FmPwQ35LXjnoE75b3hW5vvj26_xHefXz--X516vS1FLmslPUqY6rhglwFCSI1kouLLPCgMXatcZ2nDo0ihlKu8p2pq4BFbeNBMf4inw86o59SHrZSdJMCcYroaScEZdHhA2w0WP0W4g7HcDrQyLEGw0xe9OjtoYr2jDLBecCoO4Es7RjCHXLpFFm1vqy_DZ1W7QG5-VB_0z0eWXwt_om3Om6oS2fz4qcLQIx_JkwZb31yWDfw4BhOvRdNW1VSTpDP_0D_f904ogyMaQU0T02w6je--SBpfc-0YtPZtqHp4M8kh6Mwf8CRGq92g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1941324977</pqid></control><display><type>article</type><title>Untreated duration predicted the severity of depression at the two-year follow-up point</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Hung, Ching-I ; Liu, Chia-Yih ; Yang, Ching-Hui</creator><contributor>Hashimoto, Kenji</contributor><creatorcontrib>Hung, Ching-I ; Liu, Chia-Yih ; Yang, Ching-Hui ; Hashimoto, Kenji</creatorcontrib><description>No study has investigated the impact of the duration of untreated depression (DUD) on the severity of depression at the two-year follow-up point in patients with major depressive disorder (MDD) who discontinued pharmacotherapy. This study aimed to investigate this issue.
This study enrolled 155 subjects with MDD at baseline, and 101 subjects who had discontinued pharmacotherapy for 17.1 ± 5.8 months were assessed at the two-year follow-up point. DUD was defined as the interval between the onset of the index major depressive episode and the start of pharmacotherapy. The 17-item Hamilton Depression Rating Scale (HAMD) was used to evaluate depression. Multiple linear regressions were used to examine the impacts of DUD on the severity and improvement percentage (IP) of depression at follow-up.
A longer DUD was significantly associated with a greater severity and a lower IP of depression at follow-up. After controlling for confounding factors, DUD was the most significant factor predicting the severity and IP of depression at follow-up. DUD was more strongly associated with the prognosis of depression at follow-up than depression and anxiety severities at baseline.
The DUD at baseline independently predicted the severity of depression at the two-year follow-up point. Although the patients had discontinued pharmacotherapy for nearly 1.5 years, the impact of the DUD on the severity of depression persisted at follow-up. The DUD was an important index that predicted the severity of depression at the two-year follow-up point.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0185119</identifier><identifier>PMID: 28934289</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Antidepressants ; Anxiety ; Biology and Life Sciences ; Clinical medicine ; Consent ; Depressive Disorder, Major - drug therapy ; Drug therapy ; Enrollments ; Female ; Follow-Up Studies ; Hospitals ; Humans ; Illnesses ; Male ; Medical prognosis ; Medicine and Health Sciences ; Mental depression ; Patients ; People and Places ; Pharmacology ; Physical Sciences ; Predictive control ; Prognosis ; Psychiatric Status Rating Scales ; Psychiatry ; Psychotropic drugs ; Research and Analysis Methods ; Severity of Illness Index ; Social Sciences ; Studies ; Time-to-Treatment ; Treatment Outcome</subject><ispartof>PloS one, 2017-09, Vol.12 (9), p.e0185119-e0185119</ispartof><rights>2017 Hung et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 Hung et al 2017 Hung et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c577t-b90f9b39614af0a7a48d734d1d4cade5f8cdb30fec91c00b2dbc55ae93d67af13</citedby><cites>FETCH-LOGICAL-c577t-b90f9b39614af0a7a48d734d1d4cade5f8cdb30fec91c00b2dbc55ae93d67af13</cites><orcidid>0000-0002-0466-5670</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1941324977/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1941324977?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28934289$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Hashimoto, Kenji</contributor><creatorcontrib>Hung, Ching-I</creatorcontrib><creatorcontrib>Liu, Chia-Yih</creatorcontrib><creatorcontrib>Yang, Ching-Hui</creatorcontrib><title>Untreated duration predicted the severity of depression at the two-year follow-up point</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>No study has investigated the impact of the duration of untreated depression (DUD) on the severity of depression at the two-year follow-up point in patients with major depressive disorder (MDD) who discontinued pharmacotherapy. This study aimed to investigate this issue.
This study enrolled 155 subjects with MDD at baseline, and 101 subjects who had discontinued pharmacotherapy for 17.1 ± 5.8 months were assessed at the two-year follow-up point. DUD was defined as the interval between the onset of the index major depressive episode and the start of pharmacotherapy. The 17-item Hamilton Depression Rating Scale (HAMD) was used to evaluate depression. Multiple linear regressions were used to examine the impacts of DUD on the severity and improvement percentage (IP) of depression at follow-up.
A longer DUD was significantly associated with a greater severity and a lower IP of depression at follow-up. After controlling for confounding factors, DUD was the most significant factor predicting the severity and IP of depression at follow-up. DUD was more strongly associated with the prognosis of depression at follow-up than depression and anxiety severities at baseline.
The DUD at baseline independently predicted the severity of depression at the two-year follow-up point. Although the patients had discontinued pharmacotherapy for nearly 1.5 years, the impact of the DUD on the severity of depression persisted at follow-up. The DUD was an important index that predicted the severity of depression at the two-year follow-up point.</description><subject>Adult</subject><subject>Antidepressants</subject><subject>Anxiety</subject><subject>Biology and Life Sciences</subject><subject>Clinical medicine</subject><subject>Consent</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>Drug therapy</subject><subject>Enrollments</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Illnesses</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medicine and Health Sciences</subject><subject>Mental depression</subject><subject>Patients</subject><subject>People and Places</subject><subject>Pharmacology</subject><subject>Physical Sciences</subject><subject>Predictive control</subject><subject>Prognosis</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychiatry</subject><subject>Psychotropic drugs</subject><subject>Research and Analysis Methods</subject><subject>Severity of Illness Index</subject><subject>Social Sciences</subject><subject>Studies</subject><subject>Time-to-Treatment</subject><subject>Treatment Outcome</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUsFq3DAQFaWlSbf9g9IaesnFW8mSLetSKKFpA4FeGnoUY2mUaPFariQn7N_Xu-uEpBSENMy89zQzPELeM7pmXLLPmzDFAfr1GAZcU9bWjKkX5JQpXpVNRfnLJ_EJeZPShtKat03zmpxUreJivk7J7-shR4SMtrBThOzDUIwRrTf7VL7FIuEdRp93RXCFxbmW0h4E-VDN96HcIcTChb4P9-U0FmPwQ35LXjnoE75b3hW5vvj26_xHefXz--X516vS1FLmslPUqY6rhglwFCSI1kouLLPCgMXatcZ2nDo0ihlKu8p2pq4BFbeNBMf4inw86o59SHrZSdJMCcYroaScEZdHhA2w0WP0W4g7HcDrQyLEGw0xe9OjtoYr2jDLBecCoO4Es7RjCHXLpFFm1vqy_DZ1W7QG5-VB_0z0eWXwt_om3Om6oS2fz4qcLQIx_JkwZb31yWDfw4BhOvRdNW1VSTpDP_0D_f904ogyMaQU0T02w6je--SBpfc-0YtPZtqHp4M8kh6Mwf8CRGq92g</recordid><startdate>20170921</startdate><enddate>20170921</enddate><creator>Hung, Ching-I</creator><creator>Liu, Chia-Yih</creator><creator>Yang, Ching-Hui</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0466-5670</orcidid></search><sort><creationdate>20170921</creationdate><title>Untreated duration predicted the severity of depression at the two-year follow-up point</title><author>Hung, Ching-I ; Liu, Chia-Yih ; Yang, Ching-Hui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c577t-b90f9b39614af0a7a48d734d1d4cade5f8cdb30fec91c00b2dbc55ae93d67af13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Antidepressants</topic><topic>Anxiety</topic><topic>Biology and Life Sciences</topic><topic>Clinical medicine</topic><topic>Consent</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>Drug therapy</topic><topic>Enrollments</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Illnesses</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medicine and Health Sciences</topic><topic>Mental depression</topic><topic>Patients</topic><topic>People and Places</topic><topic>Pharmacology</topic><topic>Physical Sciences</topic><topic>Predictive control</topic><topic>Prognosis</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychiatry</topic><topic>Psychotropic drugs</topic><topic>Research and Analysis Methods</topic><topic>Severity of Illness Index</topic><topic>Social Sciences</topic><topic>Studies</topic><topic>Time-to-Treatment</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hung, Ching-I</creatorcontrib><creatorcontrib>Liu, Chia-Yih</creatorcontrib><creatorcontrib>Yang, Ching-Hui</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hung, Ching-I</au><au>Liu, Chia-Yih</au><au>Yang, Ching-Hui</au><au>Hashimoto, Kenji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Untreated duration predicted the severity of depression at the two-year follow-up point</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2017-09-21</date><risdate>2017</risdate><volume>12</volume><issue>9</issue><spage>e0185119</spage><epage>e0185119</epage><pages>e0185119-e0185119</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>No study has investigated the impact of the duration of untreated depression (DUD) on the severity of depression at the two-year follow-up point in patients with major depressive disorder (MDD) who discontinued pharmacotherapy. This study aimed to investigate this issue.
This study enrolled 155 subjects with MDD at baseline, and 101 subjects who had discontinued pharmacotherapy for 17.1 ± 5.8 months were assessed at the two-year follow-up point. DUD was defined as the interval between the onset of the index major depressive episode and the start of pharmacotherapy. The 17-item Hamilton Depression Rating Scale (HAMD) was used to evaluate depression. Multiple linear regressions were used to examine the impacts of DUD on the severity and improvement percentage (IP) of depression at follow-up.
A longer DUD was significantly associated with a greater severity and a lower IP of depression at follow-up. After controlling for confounding factors, DUD was the most significant factor predicting the severity and IP of depression at follow-up. DUD was more strongly associated with the prognosis of depression at follow-up than depression and anxiety severities at baseline.
The DUD at baseline independently predicted the severity of depression at the two-year follow-up point. Although the patients had discontinued pharmacotherapy for nearly 1.5 years, the impact of the DUD on the severity of depression persisted at follow-up. The DUD was an important index that predicted the severity of depression at the two-year follow-up point.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>28934289</pmid><doi>10.1371/journal.pone.0185119</doi><orcidid>https://orcid.org/0000-0002-0466-5670</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2017-09, Vol.12 (9), p.e0185119-e0185119 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1941324977 |
source | Publicly Available Content (ProQuest); PubMed Central |
subjects | Adult Antidepressants Anxiety Biology and Life Sciences Clinical medicine Consent Depressive Disorder, Major - drug therapy Drug therapy Enrollments Female Follow-Up Studies Hospitals Humans Illnesses Male Medical prognosis Medicine and Health Sciences Mental depression Patients People and Places Pharmacology Physical Sciences Predictive control Prognosis Psychiatric Status Rating Scales Psychiatry Psychotropic drugs Research and Analysis Methods Severity of Illness Index Social Sciences Studies Time-to-Treatment Treatment Outcome |
title | Untreated duration predicted the severity of depression at the two-year follow-up point |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T11%3A55%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Untreated%20duration%20predicted%20the%20severity%20of%20depression%20at%20the%20two-year%20follow-up%20point&rft.jtitle=PloS%20one&rft.au=Hung,%20Ching-I&rft.date=2017-09-21&rft.volume=12&rft.issue=9&rft.spage=e0185119&rft.epage=e0185119&rft.pages=e0185119-e0185119&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0185119&rft_dat=%3Cproquest_plos_%3E1942682270%3C/proquest_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c577t-b90f9b39614af0a7a48d734d1d4cade5f8cdb30fec91c00b2dbc55ae93d67af13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1941324977&rft_id=info:pmid/28934289&rfr_iscdi=true |